The DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.
Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases
Open accessAbstract
Apoptosis is crucial for the normal development of the nervous system, whereas neurons in the adult CNS are relatively resistant to this form of cell death. However, under pathological conditions, upregulation of death receptor family ligands, such as tumour necrosis factor (TNF), can sensitize cells in the CNS to apoptosis and a form of regulated necrotic cell death known as necroptosis that is mediated by receptor-interacting protein kinase 1 (RIPK1), RIPK3 and mixed lineage kinase domain-like protein (MLKL). Necroptosis promotes further cell death and neuroinflammation in the pathogenesis of several neurodegenerative diseases, including multiple sclerosis, amyotrophic lateral sclerosis, Parkinson disease and Alzheimer disease. In this Review, we outline the evidence implicating necroptosis in these neurological diseases and suggest that targeting RIPK1 might help to inhibit multiple cell death pathways and ameliorate neuroinflammation. Necroptosis is a form of cell death mediated by receptor-interacting protein kinase 1 (RIPK1), and is observed in several CNS disorders. Here, Yuan, Amin and Ofengeim give an overview of necroptosis in the CNS and explain its relationship with inflammation in CNS disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased activation of TNF/TNFR1 signalling following chronic activation of microglia can give rise to TNF-mediated necroptotic neuronal cell death, 160 which represents a possible therapeutic target in Parkinson's disease.161”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [161]
Experimental — accuracy not yet measuredIn the citing paper
“Yet, several genes that have been implicated in neuroinflammation38 (such as RIPK1) were seen specifically in microglial states associated with COVID-19.”
From Dysregulation of brain and choroid plexus cell types in severe COVID-19 (2021) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glutamate neurotoxicity and diseases of the nervous system
Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,188
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J. (2005) · Nature Chemical Biology · doi:10.1038/nchembio711 · Cited by 3,068
Self-citationInduction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738
Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
Sun, L., Wang, H., Wang, Z., He, S., Chen, S., Liao, D., Wang, L., Yan, J., Liu, W., Lei, X., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.031 · Cited by 2,698
Ji, Y. (1993) · Cell · doi:10.1016/0092-8674(93)90485-9 · Cited by 2,497
Cho, Y., Challa, S., Moquin, D., Genga, R., Ray, T. D., Guildford, M., & Chan, F. K.-M. (2009) · Cell · doi:10.1016/j.cell.2009.05.037 · Cited by 2,435
Kigerl, K. A., Gensel, J. C., Ankeny, D. P., Alexander, J. K., Donnelly, D. J., & Popovich, P. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3257-09.2009 · Cited by 2,130
Identification of RIP1 kinase as a specific cellular target of necrostatins
Degterev, A., Hitomi, J., Germscheid, M., Ch'en, I. L., Korkina, O., Teng, X., Abbott, D., Cuny, G. D., Yuan, C., Wagner, G., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.83 · Cited by 2,059
Self-citation
Cited by
Sorted by citations
Items 901–993 of 993
Zhuravskaya, A., Yap, K., Hamid, F., & Makeyev, E. V. (2024) · Figshare · doi:10.6084/m9.figshare.26074114
Dong, Y., Yu, H., Li, X., Bian, K., Zheng, Y., Dai, M., Feng, X., Sun, Y., He, Y., Yu, B., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20495857
Zhuravskaya, A., Yap, K., Hamid, F., & Makeyev, E. V. (2024) · Figshare · doi:10.6084/m9.figshare.26736741
Zhang, K., Li, J., & 袁恩武 (2023) · Figshare · doi:10.6084/m9.figshare.23689727
Cui, Y., Zhang, Z., Zhou, X., Zhao, Z., Zhao, R., Xu, X., Kong, X., Ren, J., Yao, X., Wen, Q., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16909773
Lin, Y., Sheng, M., Qin, H., Zhang, P., Wang, C., Fu, W., Meng, X., Wang, D., & Hou, Y. (2024) · Figshare · doi:10.6084/m9.figshare.24303417
Zhuravskaya, A., Yap, K., Hamid, F., & Makeyev, E. V. (2024) · Figshare · doi:10.6084/m9.figshare.26736720
Han, W., Fei, X., Yang, F., Sun, X., Yang, J., Qiu, J., Zhang, L., Zhang, W., Chen, G., Han, W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26667888
Cui, Y., Zhang, Z., Zhou, X., Zhao, Z., Zhao, R., Xu, X., Kong, X., Ren, J., Yao, X., Wen, Q., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16909788
Dong, Y., Yu, H., Li, X., Bian, K., Zheng, Y., Dai, M., Feng, X., Sun, Y., He, Y., Yu, B., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20495848
Zhuravskaya, A., Yap, K., Hamid, F., & Makeyev, E. V. (2024) · Figshare · doi:10.6084/m9.figshare.26736714
Zhuravskaya, A., Yap, K., Hamid, F., & Makeyev, E. V. (2024) · Figshare · doi:10.6084/m9.figshare.26074264
Lin, Y., Sheng, M., Qin, H., Zhang, P., Wang, C., Fu, W., Meng, X., Wang, D., & Hou, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24303331
Zhuravskaya, A., Yap, K., Hamid, F., & Makeyev, E. V. (2024) · Figshare · doi:10.6084/m9.figshare.26736744
Jayaraman, A., Htike, T. T., James, R., Picón, C., & Reynolds, R. (2021) · Figshare · doi:10.6084/m9.figshare.16778487
Dong, Y., Yu, H., Li, X., Bian, K., Zheng, Y., Dai, M., Feng, X., Sun, Y., He, Y., Yu, B., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20495830
Dong, Y., Yu, H., Li, X., Bian, K., Zheng, Y., Dai, M., Feng, X., Sun, Y., He, Y., Yu, B., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20495839
Wang, X., Deng, K., Tao, J., Zou, J., Du, Y., & Dai, L. (2024) · Figshare · doi:10.6084/m9.figshare.26644471
Zhuravskaya, A., Yap, K., Hamid, F., & Makeyev, E. V. (2024) · Figshare · doi:10.6084/m9.figshare.26736738
Wang, X., Deng, K., Tao, J., Zou, J., Du, Y., & Dai, L. (2024) · Figshare · doi:10.6084/m9.figshare.26644477
Hu, H., Cheng, Q., Li, D., Li, Y., Li, X., Chen, Y., Guo, Y., Tian, S., Jiang, Y., Chen, Y., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.116095
Chen, X., Wang, B., Tang, Y.-H., Yi, Y.-L., Zou, W., Tang, X.-Q., & Yang, S.-Q. (2026) · Physiology & Behavior · doi:10.1016/j.physbeh.2026.115227
Liu, C., Yan, Z., Yang, W., Han, X., Wang, L., & Liu, S. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153391
Non-apoptotic Regulated Cell Death Mechanisms in Sepsis and their Therapeutic Potential
Mitre, A. O., Neag, M. A., Bâldea, I., Filip, G. A., Mitre, B., & Pârvu, A. E. (2026) · Inflammation · doi:10.1007/s10753-025-02356-8
Tailoring treatments: pharmacogenomics in the management of neurodegenerative diseases
Roy, K. K., Kumari, R., Upadhyay, A. K., & Mohanty, S. (2026) · Acta Neurologica Belgica · doi:10.1007/s13760-025-02919-4
Spinal motor neuron degeneration after brachial plexus avulsion: mechanisms and therapeutic targets
Yang, J., Qin, B., Yang, Y., Fang, J., & He, W. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1778229
When optineurin meets innate immunity
Zhang, L., Han, J., Yang, Z., Xue, M., & Zheng, C. (2026) · Academia Immunity and Disease · doi:10.20935/acadimmunodis8165
Targeting ubiquitin-specific peptidase 22 in solid tumours: from ubiquitination to immunotherapy
Li, Z., Wang, L., Liu, J., & Tang, Y. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1792632
Guo, Y., Li, X., Chen, Y., Li, Y., Cheng, Q., Jiang, Y., Tian, S., Yuan, B., Liu, Y., Hu, H., et al. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112481
Failed, Inconclusive or Interrupted Trials in Multiple Sclerosis: 2020-2024 Update
Ricigliano, V. A. G., Szejko, N., Camera, V., Gómez‐Figueroa, E., Selmaj, K. W., & Samadzadeh, S. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.107140 · Cited by 1
RIPK1 as a potential target to augment DC efficacy in tumor immunotherapy
Mao, L. F., Ou, Y., Zhang, Y., Wang, M., Dong, G., Khanniche, A., Wang, H., Wu, Z., Zhang, H., Hu, L. Y., et al. (2026) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-026-04356-5
Research progress in PANoptosis mechanisms and their interplay with tuberculosis
Ma, X., Liang, Y., Wu, X., & An, H. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1786786
Mechanisms of programmed cell death in neurodegenerative diseases and their therapeutic potential
GENG, L., Pan, J., & Li, J. (2026) · Scientia Sinica Vitae · doi:10.1360/ssv-2025-0282
Natural Products Inhibiting Necroptosis: Molecular Mechanisms and Therapeutic Opportunities
Yang, S., Shi, Y., Liu, T., Meng, X., & Shen, X. (2026) · Journal of Visualized Experiments · doi:10.3791/70315
Machine learning and molecular simulation-based discovery of novel RIPK1 inhibitors
Hasan, M. M., Shill, M. C., Bepari, A. K., Reza, H. M., & Hossain, M. (2026) · In Silico Pharmacology · doi:10.1007/s40203-026-00586-8
Wei, H., Wang, B., Yang, J., & Liao, L. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl45499
IFN-I Induces Keratinocytes Necroptosis via ZBP1-MLKL Axis in Oral Lichen Planus
Jiang, X., Chen, J., Yao, Y., Lai, Y., Yang, X., Deng, Y., Tang, G., Sun, L., & Wang, Y. (2026) · Inflammation · doi:10.1007/s10753-026-02497-4
La nécroptose : une nouvelle cible thérapeutique dans la stéatohépatite non-alcoolique
Majdi, A. (2020) · theses.fr (ABES) · doi:10.70675/94f28bbaz6c2dz4b48zb1aaze6b48ca72708
RIPK1 ubiquitination regulates its kinase-independent function in development and inflammation
Li, M., Liu, J., Xing, M., Liu, H., Wang, L., Wu, X., Ou, Y., Zhao, X., Wang, Y., Xie, Y., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2520356123
孙晓文, Qi, Q., Ding, X., Wang, X., Shao, S., Ding, D., & Liu, Y. J. (2026) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-026-05691-0
Signaling cross-talk driving neuronal survival, death and inflammation in neurodegeneration
Singh, L. (2026) · Neurophysiology · doi:10.1007/s11062-026-10003-7
Wang, J., Zhang, B., Wu, Y., Li, W., Zhang, Y., Bao, D., Pei, H., Shi, C., She, H., Wang, X., et al. (2026) · Journal of Molecular Medicine · doi:10.1007/s00109-026-02675-9
Probing Allosteric Kinase Modulators as Next Game-Changers in Fighting Neurodegeneration
Roggiolani, E., Rosini, M., Minarini, A., & Basagni, F. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03783
RIPK3 suppresses photoreceptor degeneration in a Stargardt disease mouse modelPreprint
Wen, F., Zhai, X., He, W., Yang, Y., Tang, L., 张月华, Rôżanowska, M., Cheng, X., Li, J., Shi, J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.26.720951
Wu, Y., ZHANG, Z., Hawkins, N. J., Tang, W., & Huang, X. (2026) · JACS Au · doi:10.1021/jacsau.6c00260
Kalra, P., Grewal, A. K., Khan, H., Chaturvedi, D., & Singh, T. G. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11892-x
Wang, H., Liu, S.-Y., Chiu, C., Yeh, T., Chiu, T.-J., Yeh, Y.-C., Wu, P., & Weng, Y.-H. (2026) · Neurochemistry International · doi:10.1016/j.neuint.2026.106186
Wang, H., Liu, S.-Y., Chiu, C., Yeh, T., Chen, W.-S., Chiu, T.-J., Yeh, Y.-C., Wu, P., & Weng, Y.-H. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04762-2
Dong, R., Liu, J., Shen, Y., Wei, M., Liu, J., Liu, P., Liu, X., Zhao, S., & (151314), X. W. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.111987
TDP-43 subtypes shape transcriptomic signatures in Alzheimer’s diseasePreprint
Wang, X., Walker, A. C., Reeves, M. M., Bejarano, J. G., Song, Y., Dunmore, J. H., Yue, M., Rawlinson, B. D., Engelberg-Cook, E., Deture, M. A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.22.733827
Zhao, B., Jiang, X., Wei, X., Lan, L., Wang, R., & Li, Y. (2026) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b25-00808
Regulatory role of noncoding RNAs in infections caused by Rhabdoviridae family viruses
Mohammadzadeh, F. Z., Nabavi, A., & Karimian, M. (2026) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2026.105991
Multiomics Profiling Identifies Tlr4 as a Therapeutic Target of Necroptosis in Spinal Cord Injury
Wang, W., Sun, L., Xie, W., Chen, F., & Hong, C. (2026) · Mediators of Inflammation · doi:10.1155/mi/7306884
Yang, S., Zhou, X., Zhang, J. N., Na.PAN, Liu, M., & Song, H. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.112056
Deng, X., Xie, X., Zhou, X., Jiang, L., Zhu, T., Su, R., Chen, C., Chen, C., & Chen, C. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04922-0
Shi, Y., Tao, G., Zhang, R., Tan, W., Yang, H., Huang, Q., & Wu, Y. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119228
Cell Death in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets
Li, T., Zhang, Q., Wu, Y., & Huang, R. (2026) · MedComm · doi:10.1002/mco2.70915
Yuan, S., Han, X., Gao, S., Li, G., & Tang, C. (2026) · Journal of Radiation Research and Applied Sciences · doi:10.1016/j.jrras.2026.102613
Wang, Z., Song, H., Wang, Y., Li, F., Geng, Z., Lu, Y., Yan, C., Pei, J., & Liang, T. (2026) · Chemical Papers · doi:10.1007/s11696-026-05455-4
Zhang, S., Yu, S., Yang, D., Liu, Y., & Du, W. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115987
Discovery of novel RIPK3 inhibitors by virtual screening and bioactivity evaluation
Fu, C., Qin, L., Yang, Y., Gu, S., Zhao, W., Yao, X., & Liu, H. (2026) · Molecular Diversity · doi:10.1007/s11030-026-11680-6
Tang, L., & Fan, D. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00572-2
Sun, M., Fang, Y., Wang, Y., 高博贤, Liu, S., Chen, W., Gao, J., Sun, M., Wang, Z., & Zhong, C. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.122344
Structural characterization of PAMK and its protective effect against thymic necroptosis in goslings
Li, W., Lu, B., Zhou, X., Pan, S., Wei, J., Li, B., Cao, N., Huang, Y., Liu, W., Fu, X., et al. (2026) · Veterinary Quarterly · doi:10.1080/01652176.2026.2695104
Hu, J., Zhang, M., Liu, P., Chen, Y., Meng, H., Xia, S., Bao, X., Xu, Y., & Chen, Y. (2026) · Glia · doi:10.1002/glia.70215 · Cited by 1
Liu, D., Zhuo, Y., Chen, S., Wang, Y., Chen, X., & Yao, Y. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1845934
Yao, J., Zhang, C., Dai, X., Yu, X., Jia, X., Kuang, B., Zheng, J., Zheng, L., Teng, W., Yu, W., et al. (2026) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2026.108742
Xie, Z., Wang, Z., Fu, P., Shi, Z., Zhuang, Z., Wang, H., Xiang, Y., Yin, X., & Chen, Z. (2026) · Journal of Neurology · doi:10.1007/s00415-026-14126-z
Caccamo, A., Lanza, M., Casili, G., & Oddo, S. (2026) · Cells · doi:10.3390/cells15181692
Qi, Z., Liu, X., Geng, L., Liu, X., Dong, S., Li, J., Hua, W., Deng, Y., Lai, S., Wang, Y., et al. (2026) · Cell Death and Differentiation · doi:10.1038/s41418-026-01874-8
Chen, X., Zhao, Z., Shen, Y., Ji, Y., Yao, X., Gu, X., Qi, L., & Sun, H. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.116041
RIPK1 Links Metabolic Stresses to Inflammatory and Degenerative Pathways in Alzheimer’s Disease
Chen, X., & Zou, C. (2026) · Neuroscience Bulletin · doi:10.1007/s12264-026-01736-w
Liu, Z., Wu, S., Suo, Q., Liu, C., RuBing, S., Ye, J., Khan, H. L., Zhang, J.-Y., Tang, Y., Zhang, Z., et al. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.71053
PANoptosis in diabetic wound repair and regeneration: Current evidence and mechanistic perspectives
Wang, X., Wang, F., Wang, Z., Jin, T., Chen, Y., Xiong, K., & Yang, R. (2026) · TransMed · doi:10.1016/j.tmed.2026.100061
Wei, M., & Sun, A. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12900-w
Yu, H., Yang, H., Shi, J., Dong, W., Dong, W., Wang, Z., Meng, M., Wang, L., Wei, B., Wang, L., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-11070692/v1
BindingDB (2024) · UC San Diego · doi:10.7270/q21v5kf9
BindingDB (2025) · UC San Diego · doi:10.7270/q2hx1j85
BindingDB (2021) · UC San Diego · doi:10.7270/q27d2zmb
BindingDB Entry 50019664: From (Tool)Bench to Bedside: The Potential of Necroptosis Inhibitors.
BindingDB (2024) · UC San Diego · doi:10.7270/q2x92gpm
BindingDB Entry 50008478: Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives.
BindingDB (2021) · UC San Diego · doi:10.7270/q20k2czb
Song, M., Zhang, L., Liu, C., Liu, R., Song, F., & 赵秀兰 (2026) · Environmental Pollution · doi:10.1016/j.envpol.2026.129430
Yan, R., & Su, J. (2026) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2026.1410031
Singaravel, V. (2026) · Frontiers in Medical Technology · doi:10.3389/fmedt.2026.1958917
Metadata
- Authors
- Yuan, J., Amin, P., & Ofengeim, D.
- Affiliations
- Harvard University (US)
- Sanofi (United States) (US)
- Corresponding author
- Yuan, Junying
- Venue
- Nature Reviews Neuroscience
- Published
- 2018-11-22
- Volume
- 20
- Issue
- 1
- Pages
- 19-33
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- PMC
- PMC6342007
- OpenAlex
- W2901410206
- Semantic Scholar
- a6626d511f6ce29e1ffd0f9740b5c693cadb4fb3
- Cited by
- 967
- References
- 179
- Citations by year
- 2026: 110 · 2025: 156 · 2024: 149 · 2023: 152 · 2022: 164 · 2021: 134 · 2020: 65 · 2019: 35
- FWCI
- 5.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Denali Therapeutics
- National Institutes of Health (4r01ns082257-04)
- National Institute on Aging (RF1AG055521, R01AG047231, R21AG059073)
- National Institute of Neurological Disorders and Stroke (R01-NS082257)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- necroptosis, RIPK1, neuroinflammation, RIPK3, MLKL, apoptosis, TNF-α, death receptor ligands, neurodegenerative diseases, multiple sclerosis, amyotrophic lateral sclerosis, Parkinson's disease, Alzheimer's disease, central nervous system disorders
- MeSH terms
- Necroptosis, Animals, Brain, Humans, Inflammation, Neurons, Phosphorylation, Neurodegenerative Diseases, Receptor-Interacting Protein Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review